Have you watched Proactive presentation before???? The main point IMU wanted to delivered was the $20M raised at a premium, there's no question that doesn't get answered as these presentation are all scripted. Interest thing was LC mentioned the Ph2 clinical trial for PD1-Vaxx is starting early 2025 when the quarterly mentioned H2 2025.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)